Search research articles
Contact Us
Filters
Showing results (11-20 of 22) with videos related to
Page
of 3
Sort By:
Current Medical Research and Opinion
|
August 25, 2004
Comparing the long-term cost-effectiveness of repaglinide plus metformin versus nateglinide plus metformin in type 2 diabetes patients with inadequate glycaemic control: an application of the CORE Diabetes Model in type 2 diabetes
Andrew J Palmer, Stéphane Roze, Morten Lammert, et al.
Diabetologia
|
January 14, 2023
Congenital malformations among offspring of women with type 1 diabetes who use insulin pumps: a prospective cohort study
Ida H Thorius, Lise Lotte N Husemoen, Rikke B Nordsborg, et al.
Diabetes Research and Clinical Practice
|
December 16, 2014
Insulin degludec/insulin aspart versus biphasic insulin aspart 30 in Asian patients with type 2 diabetes inadequately controlled on basal or pre-/self-mixed insulin: a 26-week, randomised, treat-to-target trial
Shizuka Kaneko, Francis Chow, Dong Seop Choi, et al.
The Journal of Clinical Endocrinology and Metabolism
|
January 13, 2004
The insulin secretagogues glibenclamide and repaglinide do not influence growth hormone secretion in humans but stimulate glucagon secretion during profound insulin deficiency
Torben Østergård, Kristine B Degn, Mari-Anne Gall, et al.
Diabetes Care
|
December 21, 2023
Fetal Overgrowth and Preterm Delivery in Women With Type 1 Diabetes Using Insulin Pumps or Multiple Daily Injections: A Post Hoc Analysis of the EVOLVE Study Cohort
Ida Holte Thorius, Lise Lotte N Husemoen, Rikke Baastrup Nordsborg, et al.
Diabetologia
|
May 22, 2024
Development of a new health-related quality of life measure for people with diabetes who experience hypoglycaemia: the Hypo-RESOLVE QoL
Jill Carlton, Philip A Powell, Melanie Broadley, et al.
Diabetic Medicine : a Journal of the British Diabetic Association
|
February 10, 2026
'There is more to life than HbA<sub>1c</sub>': A comprehensive qualitative framework from the Hypo-RESOLVE project evidencing the impacts of hypoglycaemia on the quality of life of adults living with type 1 or type 2 diabetes
Philip A Powell, Sé M Frances, Bastiaan E de Galan, et al.
Diabetic Medicine : a Journal of the British Diabetic Association
|
November 18, 2022
Producing a preference-based quality of LIFE measure to quantify the impact of HYPOGLYCAEMIA on people living with diabetes: A mixed-methods research protocol
Jill Carlton, Philip Powell, Donna Rowen, et al.
Diabetes Care
|
July 31, 2021
Risk of Major Congenital Malformations or Perinatal or Neonatal Death With Insulin Detemir Versus Other Basal Insulins in Pregnant Women With Preexisting Diabetes: The Real-World EVOLVE Study
Elisabeth R Mathiesen, Norsiah Ali, Amra C Alibegovic, et al.
Diabetologia
|
May 25, 2024
Risk factors and prediction of hypoglycaemia using the Hypo-RESOLVE cohort: a secondary analysis of pooled data from insulin clinical trials
Joseph Mellor, Dmitry Kuznetsov, Simon Heller, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 22) with videos related to
Sort By:
Page
of 3
Current Medical Research and Opinion
|
August 25, 2004
Comparing the long-term cost-effectiveness of repaglinide plus metformin versus nateglinide plus metformin in type 2 diabetes patients with inadequate glycaemic control: an application of the CORE Diabetes Model in type 2 diabetes
Andrew J Palmer, Stéphane Roze, Morten Lammert, et al.
Diabetologia
|
January 14, 2023
Congenital malformations among offspring of women with type 1 diabetes who use insulin pumps: a prospective cohort study
Ida H Thorius, Lise Lotte N Husemoen, Rikke B Nordsborg, et al.
Diabetes Research and Clinical Practice
|
December 16, 2014
Insulin degludec/insulin aspart versus biphasic insulin aspart 30 in Asian patients with type 2 diabetes inadequately controlled on basal or pre-/self-mixed insulin: a 26-week, randomised, treat-to-target trial
Shizuka Kaneko, Francis Chow, Dong Seop Choi, et al.
The Journal of Clinical Endocrinology and Metabolism
|
January 13, 2004
The insulin secretagogues glibenclamide and repaglinide do not influence growth hormone secretion in humans but stimulate glucagon secretion during profound insulin deficiency
Torben Østergård, Kristine B Degn, Mari-Anne Gall, et al.
Diabetes Care
|
December 21, 2023
Fetal Overgrowth and Preterm Delivery in Women With Type 1 Diabetes Using Insulin Pumps or Multiple Daily Injections: A Post Hoc Analysis of the EVOLVE Study Cohort
Ida Holte Thorius, Lise Lotte N Husemoen, Rikke Baastrup Nordsborg, et al.
Diabetologia
|
May 22, 2024
Development of a new health-related quality of life measure for people with diabetes who experience hypoglycaemia: the Hypo-RESOLVE QoL
Jill Carlton, Philip A Powell, Melanie Broadley, et al.
Diabetic Medicine : a Journal of the British Diabetic Association
|
February 10, 2026
'There is more to life than HbA<sub>1c</sub>': A comprehensive qualitative framework from the Hypo-RESOLVE project evidencing the impacts of hypoglycaemia on the quality of life of adults living with type 1 or type 2 diabetes
Philip A Powell, Sé M Frances, Bastiaan E de Galan, et al.
Diabetic Medicine : a Journal of the British Diabetic Association
|
November 18, 2022
Producing a preference-based quality of LIFE measure to quantify the impact of HYPOGLYCAEMIA on people living with diabetes: A mixed-methods research protocol
Jill Carlton, Philip Powell, Donna Rowen, et al.
Diabetes Care
|
July 31, 2021
Risk of Major Congenital Malformations or Perinatal or Neonatal Death With Insulin Detemir Versus Other Basal Insulins in Pregnant Women With Preexisting Diabetes: The Real-World EVOLVE Study
Elisabeth R Mathiesen, Norsiah Ali, Amra C Alibegovic, et al.
Diabetologia
|
May 25, 2024
Risk factors and prediction of hypoglycaemia using the Hypo-RESOLVE cohort: a secondary analysis of pooled data from insulin clinical trials
Joseph Mellor, Dmitry Kuznetsov, Simon Heller, et al.
Page
of 3